Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we would like to inform you that the Earnings Call post announcement of financial results of the Company for the quarter and financial year ended 31 March 2024, is scheduled on Friday, 03 May 2024 at 05:00 p.m. IST. The Call is hosted by ICICI Securities and an invite in this regard is attached for your information and records. The above information shall be uploaded on the website of the Company at www.tatvachintan.com. Kindly take above intimation on your record and oblige.
27-04-2024
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Friday, 03.05.2024

Tatva Chintan Pharma Chem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/05/2024 ,inter alia, to consider and approve 1. consider and approve and take on record the Standalone and Consolidated Audited Financial Results of the Company for the quarter and financial year ended 31 March 2024; 2. consider and recommend a final dividend, if any, on the equity shares of the Company for the financial year ended 31 March 2024, subject to approval of the shareholders at the ensuing Annual General Meeting of the Company. Further, in accordance with the Company''s Code of Conduct for Prohibition of Insider Trading, the Company has intimated its ''''designated persons'''' regarding the closure of the Trading Window for trading in the Company''s equity shares from 01 April 2024 till the expiry of 48 hours from the date the said financial results are made public.
24-04-2024
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Compliance Certificate Pursuant To Regulation 7(3) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015, For The Year Ended 31 March 2024.

Compliance certificate pursuant to Regulation 7(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the year ended 31 March 2024.
12-04-2024
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Submission Of Certificate Under Regulation 40(9) & (10) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ended On 31 March 2024

Submission of Certificate under Regulation 40(9) & (10) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the year ended on 31 March 2024
10-04-2024
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
26-03-2024
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Closure of Trading Window

Intimation of Closure of Trading Window
26-03-2024
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
19-03-2024
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
16-03-2024
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
09-02-2024
Next Page
Close

Let's Open Free Demat Account